ImmunoVaccine Inc. | Balance Sheet
Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
3,536.00
10,662.50
3,842.40
13,546.90
14,909.30
14,895
Total Accounts Receivable
842.50
1,038.10
1,377.80
768.90
721.70
2,448
Other Current Assets
170.20
264.30
227.00
469.30
838.10
2,699
Total Current Assets
4,548.70
11,964.90
5,447.20
14,785.00
16,469.10
20,042
Net Property, Plant & Equipment
273.70
248.80
297.70
315.80
562.60
2,883
Intangible Assets
273.90
234.80
207.20
-
-
-
Total Assets
5,096.30
12,448.50
5,952.10
15,100.90
17,031.70
22,925
ST Debt & Current Portion LT Debt
56.80
66.00
59.20
57.60
60.70
Accounts Payable
559.40
607.20
838.90
954.20
1,683.60
Income Tax Payable
10.30
-
-
-
-
Other Current Liabilities
604.80
835.40
1,266.60
791.20
1,097.90
Total Current Liabilities
1,231.40
1,508.50
2,164.70
1,803.00
2,842.10
Long-Term Debt
1,274.20
3,126.10
3,718.00
6,090.40
6,475.70
Other Liabilities
-
-
-
224.30
1,371.40
Total Liabilities
2,505.50
4,634.60
5,882.70
8,117.70
10,689.20
Common Equity (Total)
2,590.80
7,813.80
69.40
6,983.20
6,342.50
Total Shareholders' Equity
2,590.80
7,813.80
69.40
6,983.20
6,342.50
Total Equity
2,590.80
7,813.80
69.40
6,983.20
6,342.50
Liabilities & Shareholders' Equity
5,096.30
12,448.50
5,952.10
15,100.90
17,031.70
About ImmunoVaccine
View Profile
